TScan Therapeutics Inc
TCRX0.896USD
-0.035-3.79%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
50.83MMarket Cap
LossP/E TTM
TScan Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
2.82M
-86.62%
EPS(YoY)
-1.14
16.29%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its total revenue reached 2.82M, with a year-on-year change of -86.62%.
What is the Earnings Per Share (EPS) of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.138, with a year-on-year change of 16.29%.
What is the net income of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its net income was -127.50M, with a year-on-year change of -42.91%.
What is the net margin of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its net profit margin was -4527.66%, with a year-on-year change of -968.20%.
What is the gross margin of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 8.64%, with a year-on-year change of -21.73%.
What is the Return on Equity (ROE) of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -65.08%, with a year-on-year change of 8.71%.
What is the Return on Assets (ROA) of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -39.64%, with a year-on-year change of -4.69%.
What is the operating profit of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its operating profit was -134.82M, with a year-on-year change of -44.26%.
What are the current assets of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its current assets were 292.72M, with a year-on-year change of 50.70%.
What are the total assets of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its total assets of TScan Therapeutics Inc were 371.12M, with a year-on-year change of 36.37%.
What are the total liabilities of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its total liabilities of TScan Therapeutics Inc were 130.15M, with a year-on-year change of 7.31%.
What is the total equity of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its total equity of TScan Therapeutics Inc was 240.97M, with a year-on-year change of 59.72%.
What is the net operating income of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its net operating income of TScan Therapeutics Inc was -127.50M, with a year-on-year change of -42.91%.
What is the net investment of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its net investment of TScan Therapeutics Inc was -52.61M, with a year-on-year change of 13.41%.
What is the net financing of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2024 earnings report, its net financing of TScan Therapeutics Inc was 208.76M, with a year-on-year change of 54.13%.
